alpha-GalCer C20 : 2 may be a more efficacious candidate drug than alpha-GalCer C26 : 0 (KRN7000) for iNKT cell mediated protection from type 1 diabetes | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

5787784

Reference Type

Journal Article

Title

alpha-GalCer C20 : 2 may be a more efficacious candidate drug than alpha-GalCer C26 : 0 (KRN7000) for iNKT cell mediated protection from type 1 diabetes

Author(s)

Ly, D; Porcelli, S; Rubin, B; Delovitch, T

Year

2008

Is Peer Reviewed?

Yes

Journal

Clinical Immunology
ISSN: 1521-6616
EISSN: 1521-7035

Publisher

Elsevier

Volume

127

Issue

Elsevier

Page Numbers

S99-S100

DOI

10.1016/j.clim.2008.03.280

Web of Science Id

WOS:000255533200285

URL

https://linkinghub.elsevier.com/retrieve/pii/S1521661608003458
Exit